Sign Up to like & get recommendations! 0
Published in 2017 at "International Ophthalmology"
DOI: 10.1007/s10792-017-0762-5
Abstract: PurposeTo investigate the safety and efficacy of a new protocol for transepithelial accelerated corneal collagen cross-linking with higher oxygen availability for keratoconus treatment.MethodsThere were 26 patients (26 eyes) diagnosed with keratoconus enrolled in the study… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "International Ophthalmology"
DOI: 10.1007/s10792-021-01713-4
Abstract: Keratoconus is a bilateral, asymmetric and progressive corneal disease. It usually results in apical thinning and steepening with corneal deformation and impaired vision. Since the early 1990 s, corneal collagen crosslinking (CXL) has remained the… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Ophthalmology"
DOI: 10.1016/j.ophtha.2017.06.011
Abstract: The development of corneal ectasia has been recognized as a complication after LASIK since the first case report from Seiler and Quurke in the late 1990s. The clinical picture of iatrogenic corneal ectasia resembles that… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Eye"
DOI: 10.1038/s41433-019-0371-9
Abstract: We thank Dr. De Bernardo et al. for their interest and their insightful comments on our recently published paper on accelerated corneal collagen cross-linking (CXL) for progressive keratoconus [1]. We fully agree that, instead of… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Klinische Monatsblatter Fur Augenheilkunde"
DOI: 10.1055/a-2040-4290
Abstract: Abstract Purpose To present a case series of rare and severe complications after corneal collagen cross-linking (CXL) of keratoconus patients. Methods Single-center descriptive case series covering the period of 2012 to 2022 at the Department… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Current Eye Research"
DOI: 10.1080/02713683.2022.2117383
Abstract: Abstract Purpose To evaluate long-term outcomes of corneal collagen crosslinking (CXL) using riboflavin and UV-A irradiation and to determine when to repeat CXL. Methods In this retrospective consecutive interventional case series 131 eyes of 131… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Ophthalmic epidemiology"
DOI: 10.1080/09286586.2021.1883677
Abstract: Objectives : To evaluate predictive factors for corneal scar formation following corneal collagen cross-linking (CXL). Methods : The medical records of 295 progressive keratoconus patients who had undergone accelerated CXL were reviewed retrospectively in this… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Cornea"
DOI: 10.1097/ico.0000000000001187
Abstract: To the Editor:Accelerated cross-linking protocols for progressive keratoconus are becoming increasingly popular because of the ability to maximize theater utilization and minimize patient discomfort. The theoretical basis for acceleration comes from the Bunsen–Roscoe law of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cornea"
DOI: 10.1097/ico.0000000000001887
Abstract: To the Editor: We read with great interest the article by Mazzotta et al.1 It is highly commendable to have a 10-year-long follow-up after an intervention; however, there is a lack of clarity regarding certain… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cornea"
DOI: 10.1097/ico.0000000000002210
Abstract: PURPOSE To evaluate the efficacy and safety of corneal collagen cross-linking with photoactivated chromophore (PACK-CXL) plus medical treatment in comparison with the non-CXL group in the management of graft infections after penetrating keratoplasty. METHODS Forty… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Acta Ophthalmologica"
DOI: 10.1111/aos.13829
Abstract: To compare the antifungal efficacy of corneal collagen cross‐linking with photoactivated riboflavin (PACK‐CXL) and voriconazole in experimental Fusarium solani and Candida albicans keratitis models. read more here.